AIP: A leader in revolutionizing healthcare in PH
Just a year after its establishment, AIP secured its nonsterile compounding license in 2014 and its sterile license in 2016. That same year, it launched its Wholesome Wellness – Local Goodness retail campaign to promote local wellness products. In 2018, the pioneer compounding pharmacy added the Pediatric category to its lineup and then Nutraceuticals in 2020. AIP became the first online compounding pharmacy in 2022, making its products even more accessible to a greater number of Filipinos.
As it marks its 10th year in the country, AIP also celebrates more than 950 actively compounded formulas, over 2,000 medical doctors, 20,000 patients and 150,000 prescriptions served. Over the years, AIP has worked with — and gained the trust of — hospitals, with more than 100 recommending the company for compounded pediatric formulas. The pharmacy recorded more than 20 percent average year-on-year growth, with 2022 being its strongest year in volume share at 30 percent.
In the past year, the top three categories that AIP served were weight loss at 38 percent, IV Nutrition at 28 percent and bio-identical hormones at 19 percent. Its top MD specialties were Aesthetics at 43 percent, Internal Medicine at 12 percent and Family Medicine at 9 percent. These categories and areas of specializations have long been part of the pharmacy’s focus even in the webinars and other awareness and knowledge-sharing initiatives that the company sponsors and supports.
To continue driving the future of specialty compounding medicines in the country, AIP plans to further expand its facilities and reach, enhance its product portfolio and strengthen partnerships while exploring new collaborations. AIP is committed to solidifying its position as a trusted provider of custom medication and empower the specialty compounding medicine market in the country through continued dedication to excellence and regulatory compliance.
Click the link below for the full article: